SPOTLIGHT -
Slideshow
Author(s):
Several non-biological factors often contribute significantly to treatment resistance.
BHV-7000 for Bipolar Disorder Fails in Phase 2/3 Trial
Blue Light, Depression, and Bipolar Disorder
FDA Accepts sNDA for Uzedy Extended-Release Injectable Suspension for Bipolar I Disorder
Four Myths About Lamotrigine
Mania and Hypomania: Latest Thinking on Diagnosis and Duration of Episodes
Largest Genetic Study of Bipolar Disorder Identifies 298 Regions of the Genome That Increase Risk for the Condition